Search results for: 'android edg poc terminals forecast 2024'
- Related search terms
- 2024 Frost & Sullivan TechnoGlobal Autonomous Clogy Innovation Leadership Award - The Global Vision Processing Unit Industry
- forecasting the global imaging market for 2025®ions=236
- forecasting the global imaging market for 2025®ions=285
- 2024 power distribution service market
- 2024 global humanoid robot market research report
-
28 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare pr...
$4,950.00 -
10 Sep 2024  |  Global  |  Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...
$4,950.00 -
26 Aug 2024  |  Global  |  Market Research
Precision Neurodegenerative Disease Market, Global, 2024 2028
Precision NDD Treatment is Experiencing Transformational Growth due to AI Capabilities, Disease-modifying Therapies, and Industry Convergence
The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...
$2,450.00 -
09 Sep 2024  |  Global  |  Technology Research
AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029
AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.
This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...
$4,950.00 -
16 Jan 2025  |  Global  |  Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...
$4,950.00 -
10 Sep 2024  |  Global  |  Technology Research
Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing
Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing
This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...
$4,950.00 -
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00